[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …
has become an established method for medical research and clinical routine diagnostics on …
Role of biomarker tests for diagnosis of neuroendocrine tumours
Neuroendocrine tumours (NETs) are neoplasms that arise from neuroendocrine cells.
Neuroendocrine cells and their tumours can secrete a wide range of amines and …
Neuroendocrine cells and their tumours can secrete a wide range of amines and …
[HTML][HTML] Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
Gallium-68 (68Ga) is a positron-emitting isotope used for clinical PET imaging of peptide
receptor expression. 68Ga radiopharmaceuticals used in molecular PET imaging consist of …
receptor expression. 68Ga radiopharmaceuticals used in molecular PET imaging consist of …
[HTML][HTML] Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the …
DL Chan, AR Hayes, I Karfis, A Conner… - British Journal of …, 2023 - nature.com
Abstract Background Gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) are
heterogeneous in clinical course, biology, and outcomes. The NETPET score predicts …
heterogeneous in clinical course, biology, and outcomes. The NETPET score predicts …
[HTML][HTML] Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine …
RP Baum, HR Kulkarni, A Singh, D Kaemmerer… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Methods In our center, 2294 patients were screened between 2004 and 2014 by 68 Ga
somatostatin receptor (SSTR) PET/CT. Intention to treat analysis included 1048 patients …
somatostatin receptor (SSTR) PET/CT. Intention to treat analysis included 1048 patients …
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
L Bodei, MS Kidd, A Singh, WA van der Zwan… - European journal of …, 2020 - Springer
Purpose Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable
neuroendocrine tumors (NETs). Imaging response assessment is usually efficient …
neuroendocrine tumors (NETs). Imaging response assessment is usually efficient …
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
L Bodei, MS Kidd, A Singh, WA Van Der Zwan… - European journal of …, 2018 - Springer
Background Peptide receptor radionuclide therapy (PRRT) utilizes somatostatin receptor
(SSR) overexpression on neuroendocrine tumors (NET) to deliver targeted radiotherapy …
(SSR) overexpression on neuroendocrine tumors (NET) to deliver targeted radiotherapy …
Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions
CM Deroose, E Hindié, E Kebebew… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine
has earned a major role in gastroenteropancreatic neuroendocrine tumors (GEP NETs) …
has earned a major role in gastroenteropancreatic neuroendocrine tumors (GEP NETs) …
The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United …
E Skoura, S Michopoulou… - Journal of Nuclear …, 2016 - Soc Nuclear Med
68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …
[PDF][PDF] What is new in the 2017 World Health Organization classification and 8th American Joint Committee on Cancer staging system for pancreatic neuroendocrine …
The diagnosis and management of pancreatic neuroendocrine neoplasms (NENs) have
evolved significantly in recent years. There are several diagnostic and therapeutic …
evolved significantly in recent years. There are several diagnostic and therapeutic …